Gene expression product BLSJ-1 with Brucella diagnosis and identification effect, and preparation method thereof
A BLSJ-1, Brucella technology, applied in botanical equipment and methods, biochemical equipment and methods, genetic engineering, etc., can solve problems such as inability to distinguish brucella vaccine immune antibodies
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] ——Screening research of differential diagnosis antigen protein spots
[0048] Differential diagnostic antigens were screened from membrane proteins of S2 strain by immunoproteomics method. Each of 30 brucellosis-negative healthy sheep, 30 S2 immunized sheep, and 30 clinical brucellosis-infected sheep-positive mixed sera were used for western-blotting (Western-blotting) with S2 strain membrane protein two-dimensional electrophoresis gel (2D), respectively. Looking for the difference between the S2 membrane protein and the serum reaction of sheep with different brucellosis status (infected / immune / negative), a total of 113 differential protein spots were found. A total of 30 protein spots with large differences in immune response were selected for matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry identification and bioinformatics analysis. A total of 14 proteins were identified. These proteins undertake 13 types of molecular functions...
Embodiment 2
[0073] ——Determination of gene information of differential diagnosis antigen protein spot
[0074]The candidate protein spots obtained by the two methods were compared with the expressed proteins in the S2 genome information published on the website of the National Center for Biotechnology Information (NCBI), and the corresponding gene information of each candidate protein spot was obtained in Table 3 (including gene name information, Gene number, gene length, protein molecular weight, etc.), then respectively design primers and use PCR for gene cloning to obtain prokaryotic expression products (Table 3, image 3 , Figure 4 ), respectively with Brucella immune serum and Brucella natural infection serum by Western-blot (Western-blot) and indirect enzyme-linked immunosorbent assay (ELISA) to verify its differential diagnosis value ( Figure 5 ,Table 4).
[0075] 1. Eight candidate differential diagnosis antigens (Table 3), numbered #1-#8 respectively, and protein numbers are ...
Embodiment 3
[0092] ——2# (BLSJ-1, universal stress protein, universal stress protein) differential diagnosis effect verification
[0093] 1. Utilize glutathione S-transferase (GST) affinity chromatography column and glutathione gradient elution method to purify recombinant protein 8#, obtain the purified target protein of purity more than 90% ( Image 6 ).
[0094] 2. The results of enzyme-linked immunosorbent assay (ELISA) detection of purified 2# recombinant protein (BLSJ-1) brucellosis antibody
[0095] Purified 2# recombinant protein under conventional conditions: choose 3 single parts of negative / immune / infected sera and 1 part of mixed negative / immune / infected sera, respectively use carbonate buffer solution of pH 9.6 to purify the recombinant protein The protein antigen was diluted to 100ng / mL, coated overnight at 4°C, blocked with 10% skimmed milk for 2 hours as a blocking solution, diluted 1:50 with PBS, and 1:50 for the enzyme-labeled secondary antibody with phosphate buffered s...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com